Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001225109 | SCV001397345 | pathogenic | Capillary malformation-arteriovenous malformation syndrome | 2019-03-27 | criteria provided, single submitter | clinical testing | This variant has been observed in a family affected with RASA1-related disease (PMID: 24038909). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser122*) in the RASA1 gene. It is expected to result in an absent or disrupted protein product. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in RASA1 are known to be pathogenic (PMID: 24038909). |